Interesting facts about cTTP you may not have known before
Learning some facts about cTTP can help you stay connected and discover more about it, in a simple way. Read on to find out more.
Fact #1: cTTP is a form of TTP but there is also a different form called iTTP1
TP (or thrombotic thrombocytopenic purpura) is a rare, life-threatening blood condition in which blood clots form throughout small blood vessels of the body.2 These blood clots can impair the normal flow of blood, leading to organ damage and other complications.2 A person can be born with this condition—due to an affected gene—in which case it is called congenital TTP (cTTP). However, they can also develop it later in life—due to their immune system response—in which case it is called immune-mediated or acquired TTP (iTTP).2 You can read more about the difference between cTTP and iTTP here.
Fact #2: About 0.5 to 2 persons per million worldwide are thought to have cTTP1
cTTP is in fact, one of a select group of conditions sometimes referred to as “ultra-rare” as it is so uncommon.3
Fact #3: There can, sometimes, be an average delay of almost 4 years before someone experiences their first symptoms and is then diagnosed with cTTP4
As cTTP is so rare, it may not be the first thing that comes to mind during medical or health consultations. Unfortunately, a delayed diagnosis – or a wrong diagnosis – might sometimes mean unnecessary tests and treatments for those affected. Click here to find out more about the symptoms of cTTP.
Fact #4: Flare-ups of cTTP may be triggered by infections, some drugs, and pregnancy5
Consider speaking to your care team if you have any concerns or questions about your condition flaring up – such as if you are worried about whether it is safe to start a new medication.
Fact #5: cTTP is also known as Upshaw-Schulman syndrome1
cTTP was discovered in the USA in the 1960s and 1970s, largely due to the efforts of two researchers called Upshaw and Schulman.6 This is why it has been named after them.
Fact #6: cTTP occurs when a protein in the blood called ADAMTS13 is missing or at very low levels
An enzyme called ADAMTS13 helps control clotting of the blood.2 People with cTTP are born with a fault in the gene that makes ADAMTS13 in the body.1,2 The results in a deficiency of this enzyme.1 This ultimately means there is an increased risk of blood clotting.2 You can read more about cTTP here.
Fact #7: The current treatments for cTTP are infusion therapies which aim to replace the missing blood protein ADAMTS137
These treatments need to be given in hospital and can take hours to administer.7 Scientists are searching for new treatments that can be given at home. You can ask your care team for any updates or information about cTTP treatments.